A new blood test, which has the potential to accurately diagnose Alzheimer’s disease in individuals and significantly advance drug testing and research on the disease, has been developed through grant funding by Cure Alzheimer's Fund.
The test, known as Immunosignature (IS) and developed by a team led by UCLA neurologist Lucas Resrepo, uses a special method of fluorescent tagging of antibodies in the blood to recognize an identifiable binding pattern—or antibody "signature"—associated with Alzheimer's.
In their study to be presented at the 2014 American Academy of Neurology Meeting in Philadelphia, Restrepo and colleagues were able to use the test to distinguish Alzheimer's patients from elderly people without dementia with 95% accuracy.
Full Article and Source:
Diagnosing Alzheimer's: New Blood Test Suggests Possible Breakthrough
2 comments:
Exciting news!
I hope so. It's a good step toward defeating the disease.
Post a Comment